dr. mok on improving lung cancer drug development
Published 11 years ago • 655 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:28
dr. mok discusses developing lung cancer treatments
-
0:44
dr. mok on dacomitinib for first-line lung cancer treatment
-
1:53
dr. mok on the utility of afatinib in lung cancer
-
0:59
dr. mok gives an overview of plasma testing approaches for lung cancer
-
1:02
dr. mok on overall survival data from the alex trial in alk lung cancer
-
0:49
dr. mok on plasma testing in lung cancer
-
9:57
【有星有say】莫樹錦 專訪
-
39:45
intermittent fasting & cancer - what health benefits can fasting unlock?
-
47:57
lung cancer new treatment 2023
-
1:18
dr. mok on breakthrough therapies for alk-positive nsclc
-
58:19
the implications of recent datasets for the current and future management of nsclc egfr mutations
-
2:56
dr bazhenova on improving biomarker development in lung cancer
-
2:12
dr. mok discusses updated data with pembrolizumab in nsclc
-
1:50
developments and challenges in met targeting for lung cancer
-
53:37
taofeek owonikoko, md, phd on lung and thyroid cancers and early phase drug development
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
1:38
dr. mok discusses next steps for pembrolizumab in nsclc
-
20:25
wclc 2024 highlights - exploring latest advances in lung cancer treatment
-
4:59
challenges in targeted drug development and treatment in lung cancer
-
1:03
dr. lynch discusses challenges associated with molecular targeted therapies in lung cancer
-
54:19
updating the lung cancer treatment algorithms with novel antibody–drug conjugates
-
23:52
s1 episode 2: biomarkers and targeted therapies for lung cancer